Waters Corporation and Bruker BioSciences Corporation, Billerica, MA, have entered into a collaboration agreement to provide integration and connectivity between Waters® ACQUITY Ultra Performance LC™ system and Bruker's mass spectrometry and nuclear magnetic resonance products.
The collaboration will allow direct support of Waters ACQUITY UPLC System in Bruker’s HyStar™ software thus unifying control and results management to combine these complementary technologies.
The products of both companies play an important role in the discovery, development, and manufacture of pharmaceuticals, processed foods, beverages, personal care products, and in environmental and food safety laboratories.
"Scientists are always looking for a competitive edge and many have experienced the advantages of using UPLC with MS," said Rohit Khanna, Ph.D., Vice President - Worldwide Marketing, Waters Corporation.
"Combining UPLC with mass spectrometry brings scientists measurable improvements in performance and in the overall quality of information they obtain from their LC/MS and LC/NMR analyses resulting in improved decision-making, increased productivity and reduced business risk."